<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03660891</url>
  </required_header>
  <id_info>
    <org_study_id>OS NMBcentralperipheral</org_study_id>
    <nct_id>NCT03660891</nct_id>
  </id_info>
  <brief_title>OS NMB Depth Measured by Central and Peripheral Monitor.</brief_title>
  <official_title>Observational Study Measuring Neuromuscular Block Depth by a TOF or PTC Monitor on the Thumb and on the Upper Arm of the Same Side.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AZ Sint-Jan AV</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AZ Sint-Jan AV</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparing during anesthesia in the same patient 2 neuromuscular monitors on the same arm.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      NMT (neuromuscular transmission) depth can be measured at the same arm with two different
      methods during clinical practice.

      the first (TOF Watch) measures the musculus adductor pollicis acceleration while the second
      method (TOF Cuff Monitor) uses a blood pressure cuff to measure the pressure changes induced
      by the upper arm muscles.

      During general anesthesia when NMB (neuromuscular block) is required both methods are used.
      Every 5 minutes, if clinical required, the NMB is monitored by TOF-PTC. If the measurement of
      TOF is zero the monitor continues by measuring PTC ( the system will measure TOF followed by
      PTC if TOF is zero) TOF-PTC is recorded and later compared for identity or systematic
      difference in one or the other direction.

      The measured answer can be TOF 4 (4 answers) with a ratio between answer 1 and 4 expressed
      and a percentage, TOF 3 (3 answers), TOF 2, TOF 1, TOF 0 + PTC 20, TOF 0 + PTC 19, up to TOF
      0 + PTC 0
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>TOF-PTC value</measure>
    <time_frame>From induction of anesthesia (intubation with ETT) till end of anesthesia (extubation of ETT) most frequent between 1 and 2 hours, max 6 hours in duration</time_frame>
    <description>Difference in TOF-PTC measured by two different devices during anesthesia.</description>
  </primary_outcome>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Neuromuscular Blockade</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>measuring neuromuscular block</intervention_name>
    <description>During anesthesia patients are monitored with two instead of one NMT monitor. the difference in measured TOF-PTC is compared</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        all patients undergo a laparoscopic surgery and require a deep NMB.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria: all patients scheduled for an elective surgery requiring neuromuscular
        block during anesthesia

          -  laparoscopic surgery of upper abdomen including all types of bariatric surgery.

        Exclusion Criteria: not possible to measure NMT (neuromuscular transmission) by cuff or
        thumb monitor

          -  upper arm obesity excluding the use of an upper arm blood pressure cuff

          -  allergy to NMB (neuromuscular blockers)

          -  contra indication for a deep NMB
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jan Paul Mulier</last_name>
    <role>Principal Investigator</role>
    <affiliation>AZSint Jan AV</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jan Paul Mulier, PhD</last_name>
    <phone>003259452490</phone>
    <email>jan.mulier@azsintjan.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kris Leleu, MD</last_name>
    <phone>003250452490</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Azsintjan</name>
      <address>
        <city>Brugge</city>
        <zip>8000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <contact>
      <last_name>j p mulier, MD PhD</last_name>
      <phone>00 32 50 45 21 93</phone>
      <email>anesthesie@azsintjan.be</email>
    </contact>
    <investigator>
      <last_name>jan P mulier, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>August 19, 2018</study_first_submitted>
  <study_first_submitted_qc>September 4, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 7, 2018</study_first_posted>
  <last_update_submitted>March 20, 2020</last_update_submitted>
  <last_update_submitted_qc>March 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>AZ Sint-Jan AV</investigator_affiliation>
    <investigator_full_name>Jan Mulier</investigator_full_name>
    <investigator_title>principle investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

